ONCT logo

Oncternal Therapeutics (ONCT) Gross Profit

Annual Gross Profit

N/A

December 31, 2023


Summary


Performance

ONCT Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherONCTprofitabilitymetrics:

Quarterly Gross Profit

N/A

September 30, 2024


Summary


Performance

ONCT Quarterly Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherONCTprofitabilitymetrics:

TTM Gross Profit

N/A

September 30, 2024


Summary


Performance

ONCT TTM Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherONCTprofitabilitymetrics:

Gross Profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

ONCT Gross Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

ONCT Gross Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time

Oncternal Therapeutics Gross Profit History

DateAnnualQuarterlyTTM
Sep 2011
-
$0.00(-100.0%)
$10.47 M(-9.3%)
Jun 2011
-
$1.38 M(-84.8%)
$11.55 M(+5.3%)
Mar 2011
-
$9.09 M(+741.7%)
$10.97 M(-82.3%)
Sep 2010
-
$1.08 M(+34.8%)
$61.82 M(-3.4%)
Jun 2010
-
$801.00 K(-98.6%)
$63.99 M(-3.9%)
Mar 2010
-
$56.43 M(+1507.6%)
$66.58 M(+395.4%)
Dec 2009
$13.44 M(+4.4%)
$3.51 M(+7.8%)
$13.44 M(+5.3%)
Sep 2009
-
$3.26 M(-4.0%)
$12.76 M(+3.2%)
Jun 2009
-
$3.39 M(+3.3%)
$12.36 M(+4.6%)
Mar 2009
-
$3.28 M(+16.0%)
$11.82 M(-8.2%)
Dec 2008
$12.88 M
$2.83 M(-0.9%)
$12.88 M(+9.1%)
Sep 2008
-
$2.86 M(+0.1%)
$11.81 M(+12.1%)
Jun 2008
-
$2.85 M(-34.2%)
$10.53 M(+13.3%)
DateAnnualQuarterlyTTM
Mar 2008
-
$4.34 M(+146.6%)
$9.30 M(+42.9%)
Dec 2007
$6.50 M(-3.4%)
$1.76 M(+11.1%)
$6.50 M(-30.3%)
Sep 2007
-
$1.58 M(-2.1%)
$9.33 M(+7.2%)
Jun 2007
-
$1.62 M(+4.6%)
$8.70 M(+15.4%)
Mar 2007
-
$1.55 M(-66.3%)
$7.54 M(+11.9%)
Dec 2006
$6.73 M(+204.8%)
$4.58 M(+380.3%)
$6.73 M(+161.6%)
Sep 2006
-
$954.00 K(+110.6%)
$2.57 M(+25.1%)
Jun 2006
-
$453.00 K(-39.0%)
$2.06 M(-18.1%)
Mar 2006
-
$743.00 K(+75.7%)
$2.51 M(+13.6%)
Dec 2005
$2.21 M(>+9900.0%)
$423.00 K(-3.2%)
$2.21 M(+23.7%)
Sep 2005
-
$437.00 K(-51.8%)
$1.79 M(+32.4%)
Jun 2005
-
$907.00 K(+105.2%)
$1.35 M(+205.2%)
Mar 2005
-
$442.00 K
$442.00 K
Dec 2001
$0.00
-
-

FAQ

  • What is the all time high annual gross profit for Oncternal Therapeutics?
  • What is the all time high quarterly gross profit for Oncternal Therapeutics?
  • What is the all time high TTM gross profit for Oncternal Therapeutics?

What is the all time high annual gross profit for Oncternal Therapeutics?

Oncternal Therapeutics all-time high annual gross profit is $13.44 M

What is the all time high quarterly gross profit for Oncternal Therapeutics?

Oncternal Therapeutics all-time high quarterly gross profit is $56.43 M

What is the all time high TTM gross profit for Oncternal Therapeutics?

Oncternal Therapeutics all-time high TTM gross profit is $66.58 M